IN190794B - - Google Patents

Info

Publication number
IN190794B
IN190794B IN2884DE1998A IN190794B IN 190794 B IN190794 B IN 190794B IN 2884DE1998 A IN2884DE1998 A IN 2884DE1998A IN 190794 B IN190794 B IN 190794B
Authority
IN
India
Application number
Other languages
English (en)
Inventor
Akihiro Masuyama
Toshiaki Takano
Original Assignee
Calpis Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Calpis Co Ltd filed Critical Calpis Co Ltd
Publication of IN190794B publication Critical patent/IN190794B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55Protease inhibitors
    • A61K38/556Angiotensin converting enzyme inhibitors
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/18Peptides; Protein hydrolysates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06Tripeptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Nutrition Science (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Vascular Medicine (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Dairy Products (AREA)
  • Confectionery (AREA)
  • Peptides Or Proteins (AREA)
IN2884DE1998 1997-09-26 1998-09-25 IN190794B (US06559137-20030506-C00182.png)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP26242297A JP4727770B2 (ja) 1997-09-26 1997-09-26 尿中カテコールアミン低下、尿中ノルアドレナリン低下、尿中ドーパミン低下及びFischer比低下の少なくとも1つの軽減剤

Publications (1)

Publication Number Publication Date
IN190794B true IN190794B (US06559137-20030506-C00182.png) 2003-08-23

Family

ID=17375571

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2884DE1998 IN190794B (US06559137-20030506-C00182.png) 1997-09-26 1998-09-25

Country Status (23)

Country Link
US (1) US6410685B1 (US06559137-20030506-C00182.png)
EP (1) EP1018341B1 (US06559137-20030506-C00182.png)
JP (1) JP4727770B2 (US06559137-20030506-C00182.png)
KR (2) KR100379819B1 (US06559137-20030506-C00182.png)
CN (1) CN1198641C (US06559137-20030506-C00182.png)
AT (1) ATE264687T1 (US06559137-20030506-C00182.png)
AU (1) AU728565B2 (US06559137-20030506-C00182.png)
BG (1) BG64692B1 (US06559137-20030506-C00182.png)
BR (1) BR9813222A (US06559137-20030506-C00182.png)
CA (1) CA2303810C (US06559137-20030506-C00182.png)
CZ (1) CZ298848B6 (US06559137-20030506-C00182.png)
DE (1) DE69823369T2 (US06559137-20030506-C00182.png)
DK (1) DK1018341T3 (US06559137-20030506-C00182.png)
ES (1) ES2219868T3 (US06559137-20030506-C00182.png)
HU (1) HUP0004617A3 (US06559137-20030506-C00182.png)
ID (1) ID25635A (US06559137-20030506-C00182.png)
IN (1) IN190794B (US06559137-20030506-C00182.png)
PL (1) PL192873B1 (US06559137-20030506-C00182.png)
PT (1) PT1018341E (US06559137-20030506-C00182.png)
SK (1) SK285148B6 (US06559137-20030506-C00182.png)
TR (1) TR200000863T2 (US06559137-20030506-C00182.png)
TW (1) TWI231213B (US06559137-20030506-C00182.png)
WO (1) WO1999016461A1 (US06559137-20030506-C00182.png)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ334627A (en) * 1999-03-12 2002-07-26 Horticulture & Food Res Inst A therapeutic composition containing a therapeutic agent such as an anthelmintic and an antistress agent such as metyrapone or a nitric oxide promoter for increasing efficacy of therapeutic agents and animal growth
FR2793257B1 (fr) * 1999-05-06 2001-07-27 Gervais Danone Sa Bacteries lactiques a proprietes anxiolytiques, et leurs utilisations
FI113741B (fi) * 1999-11-01 2004-06-15 Valio Oy Menetelmä verenpainetta alentavia peptidejä sisältävän tuotteen valmistamiseksi
JP4633876B2 (ja) * 1999-11-11 2011-02-16 カルピス株式会社 トリペプチドの製造方法
US8178150B2 (en) 2000-02-22 2012-05-15 Suzanne Jaffe Stillman Water containing soluble fiber
US7892586B2 (en) 2001-02-22 2011-02-22 Suzanne Jaffe Stillman Water containing soluble fiber
DE10105040A1 (de) 2001-02-05 2002-08-14 Tell Pharm Ag Hergiswil Tripeptid-Derivate für die Behandlung von postläsionalen Krankheiten des Nervensystems
DE10105038B4 (de) 2001-02-05 2005-07-07 Neurotell Ag Tripeptid-Derivate für die Behandlung von postläsionalen Krankheiten des Nervensystems
DE10105041A1 (de) * 2001-02-05 2002-08-14 Tell Pharm Ag Hergiswil Tripeptide und Tripeptid-Derivate für die Behandlung neurodegenerativer Krankheiten
EP1509609B1 (en) 2002-06-04 2015-04-22 DSM IP Assets B.V. Protein hydrolysate rich in tripeptides
US20050222263A1 (en) * 2002-09-18 2005-10-06 Ajinomoto Co., Inc. Compositions against stress-related diseases and methods for treating stress-related diseases
WO2004026296A1 (ja) * 2002-09-18 2004-04-01 Ajinomoto Co., Inc. 抗ストレス性疾患組成物
TWI411441B (zh) 2003-03-18 2013-10-11 Suntory Holdings Ltd 血管收縮素轉化酶抑制性肽類
WO2004098309A1 (en) * 2003-05-05 2004-11-18 Unilever N.V. Hydrolysed casein product comprising tripeptides ipp and/ or vpp
US20080292750A1 (en) * 2004-03-19 2008-11-27 Camoina Nederland Holding B.V. Method of Preparing a Food Ingredient and Food Product Having Angiotensin-I-Converting Enzyme Inhibiting Properties and Products Thus Obtained
JP2008505653A (ja) * 2004-07-12 2008-02-28 ディーエスエム アイピー アセッツ ビー.ブイ. 血圧降下タンパク質加水分解物
WO2006089921A1 (en) * 2005-02-24 2006-08-31 Dsm Ip Assets B.V. Blood pressure lowering peptides from glycomacropeptide
US20100151080A1 (en) * 2005-07-26 2010-06-17 Calpis Co., Ltd. Process for production of fermented milk and fermented milk beverage/food
US20100166859A1 (en) * 2006-01-16 2010-07-01 Luppo Edens Novel nutraceutical compositions and use thereof
EP2040732A4 (en) * 2006-05-15 2009-08-19 Valio Ltd NEW USE OF THERAPEUTICALLY USEFUL PEPTIDES
JP5394628B2 (ja) * 2007-02-09 2014-01-22 クロスフィールドバイオ株式会社 新規なラクトバチルス属微生物および乳酸菌製剤
JP2011504464A (ja) * 2007-11-14 2011-02-10 ディーエスエム アイピー アセッツ ビー.ブイ. 新規血圧降下組成物
JP5618395B2 (ja) * 2009-08-13 2014-11-05 カルピス株式会社 自律神経活動調節用組成物および自律神経を調節する方法
JP2011136932A (ja) 2009-12-28 2011-07-14 Calpis Co Ltd 脳機能改善用組成物および脳機能を改善する方法
JP2010183918A (ja) * 2010-06-01 2010-08-26 Calpis Co Ltd トリペプチドの製造方法
CN102399261B (zh) * 2010-09-07 2014-06-25 任发政 具有血管紧张素转化酶c-端选择性抑制活性的三肽及其应用和组合物
JP2011102331A (ja) * 2011-02-17 2011-05-26 Calpis Co Ltd 尿中ドーパミン低下の予防及び軽減剤
JP5892687B2 (ja) 2011-07-07 2016-03-23 高砂香料工業株式会社 風味改善ペプチド
CN103204909B (zh) * 2013-04-17 2014-09-03 苏州凯祥生物科技有限公司 一种抗高血压活性肽vppipp
JP5853326B2 (ja) * 2013-12-24 2016-02-09 カルピス株式会社 自律神経活動調節用組成物および自律神経を調節する方法
JP2014208702A (ja) * 2014-07-31 2014-11-06 カルピス株式会社 自律神経活動調節用組成物および自律神経を調節する方法
CN104725485B (zh) * 2014-11-19 2018-01-16 扬州大学 一种重组活性肽及其同步制备方法
JPWO2017057319A1 (ja) * 2015-09-30 2018-07-19 株式会社明治 乳酸菌スターターの調製方法及び発酵乳の製造方法
CN111909978B (zh) * 2020-07-10 2021-06-22 青岛农业大学 一种利用发酵法从玉米蛋白粉中定向制备富含lpp水解物的方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5189064A (en) * 1985-07-22 1993-02-23 Matrix Technologies, Inc. Treatment of cocaine addiction
GB2227658A (en) * 1989-02-03 1990-08-08 Cellana Thyrotropin releasing hormone (trh) composition for enhancing immune function
IE70080B1 (en) * 1989-02-16 1996-10-30 Sankyo Co Peptides having renin inhibitory activity their preparation and use
US5593967A (en) * 1990-08-31 1997-01-14 Warner-Lambert Company Cholecystokinin antagonists, their preparation and therapeutic use
US5264419A (en) * 1990-08-31 1993-11-23 Warner-Lambert Company N-substituted cycloalkyl and polycycloalkyl α-substituted TRP derivatives
JP2904655B2 (ja) * 1992-09-17 1999-06-14 サントリー株式会社 抗ストレス剤
US5639729A (en) * 1993-08-26 1997-06-17 Immunobiology Research Institute, Inc. Tripeptides useful in immune and CNS therapy
US5604198A (en) * 1994-05-12 1997-02-18 Poduslo; Joseph F. Method to enhance permeability of the blood/brain blood/nerve barriers to therapeutic agents
JPH08275752A (ja) * 1995-04-07 1996-10-22 Riken Vitamin Co Ltd ストレス改善食品
JPH0920660A (ja) * 1995-07-04 1997-01-21 Suntory Ltd 抗ストレス組成物
JP4065038B2 (ja) * 1996-08-07 2008-03-19 カルピス株式会社 計算作業負荷ストレス緩和剤

Also Published As

Publication number Publication date
ES2219868T3 (es) 2004-12-01
TR200000863T2 (tr) 2000-11-21
EP1018341A4 (en) 2002-08-28
KR100383492B1 (ko) 2003-05-12
KR20030005137A (ko) 2003-01-15
HUP0004617A3 (en) 2001-11-28
HUP0004617A2 (hu) 2001-05-28
CN1198641C (zh) 2005-04-27
EP1018341B1 (en) 2004-04-21
CA2303810C (en) 2007-03-27
PT1018341E (pt) 2004-08-31
CA2303810A1 (en) 1999-04-08
PL192873B1 (pl) 2006-12-29
PL339348A1 (en) 2000-12-18
DK1018341T3 (da) 2004-07-26
CZ298848B6 (cs) 2008-02-27
SK285148B6 (sk) 2006-07-07
JP4727770B2 (ja) 2011-07-20
DE69823369T2 (de) 2005-05-04
SK4362000A3 (en) 2001-03-12
US6410685B1 (en) 2002-06-25
CZ20001083A3 (cs) 2001-01-17
AU728565B2 (en) 2001-01-11
BG104381A (en) 2001-02-28
ATE264687T1 (de) 2004-05-15
TWI231213B (en) 2005-04-21
EP1018341A1 (en) 2000-07-12
JPH11100328A (ja) 1999-04-13
BR9813222A (pt) 2000-08-29
BG64692B1 (bg) 2005-12-30
ID25635A (id) 2000-10-19
AU5780198A (en) 1999-04-23
WO1999016461A1 (fr) 1999-04-08
CN1279614A (zh) 2001-01-10
DE69823369D1 (de) 2004-05-27
KR20010024277A (ko) 2001-03-26
KR100379819B1 (ko) 2003-04-14

Similar Documents

Publication Publication Date Title
IN190794B (US06559137-20030506-C00182.png)
CH0944937H2 (US06559137-20030506-C00182.png)
IN188653B (US06559137-20030506-C00182.png)
ITMI971471A0 (US06559137-20030506-C00182.png)
IN190398B (US06559137-20030506-C00182.png)
IN191155B (US06559137-20030506-C00182.png)
ITTO970551A0 (US06559137-20030506-C00182.png)
BR9701757A (US06559137-20030506-C00182.png)
ECSMU970115U (US06559137-20030506-C00182.png)
GR1004743B (US06559137-20030506-C00182.png)
IN180613B (US06559137-20030506-C00182.png)
ITMI970988A0 (US06559137-20030506-C00182.png)
CN3056209S (US06559137-20030506-C00182.png)
CN3054162S (US06559137-20030506-C00182.png)
CN3055603S (US06559137-20030506-C00182.png)
CN3058025S (US06559137-20030506-C00182.png)
CN3055519S (US06559137-20030506-C00182.png)
CN3056251S (US06559137-20030506-C00182.png)
CN3055471S (US06559137-20030506-C00182.png)
CN3055389S (US06559137-20030506-C00182.png)
CN3055179S (US06559137-20030506-C00182.png)
CN3055123S (US06559137-20030506-C00182.png)
CN3056276S (US06559137-20030506-C00182.png)
CN3056417S (US06559137-20030506-C00182.png)
CN3056418S (US06559137-20030506-C00182.png)